<bill session="118" type="h" number="5801" updated="2025-11-19T04:33:12Z">
  <state datetime="2023-09-28">REFERRED</state>
  <status>
    <introduced datetime="2023-09-28"/>
  </status>
  <introduced datetime="2023-09-28"/>
  <titles>
    <title type="display">Preventing Overdoses with Test Strips Act</title>
    <title type="short" as="introduced">Preventing Overdoses with Test Strips Act</title>
    <title type="official" as="introduced">To ensure that expenses relating to the acquisition or use of devices for use in the detection of fentanyl, xylazine, and other emerging adulterant substances, including test strips, are allowable expenses under certain grant programs.</title>
  </titles>
  <sponsor bioguide_id="G000583"/>
  <cosponsors>
    <cosponsor bioguide_id="B001298" joined="2023-09-28"/>
    <cosponsor bioguide_id="G000574" joined="2023-09-28"/>
    <cosponsor bioguide_id="L000599" joined="2024-02-06"/>
  </cosponsors>
  <actions>
    <action datetime="2023-09-28">
      <text>Introduced in House</text>
    </action>
    <action datetime="2023-09-28" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2023-09-29">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referred To"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="118" type="s" number="2976" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Health programs administration and funding"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Medical tests and diagnostic methods"/>
  </subjects>
  <amendments/>
</bill>
